Keywords: DNA damage, Free radicals, Radioprotector, Tocopherol monoglucoside (TMG) .... and as a result, survival was only brought down to. 11 % after 6 Gy dose. .... Cma,. 1.4. 3.2. Cmaxcal. 1.432. 436.565. T max. 10.00. 5.00. Tmaxcal. 11.68. 17.30
Aug 13, 2013 - inflammatory cytokines and free radicals, increase production and bioavailability of nitric oxide, and con- sequently atherosclerosis development . In human trials, consumption of high-polyphenol dark chocolate was accompanied with
Aug 15, 2013 - The pKa values of marinopyrrole A (1) are predicted to be 7.8 (pKa 1) ..... (d, J = 8.4 Hz, 2H) ppm; 13C NMR (CDCl3, 100 MHz) Î´ 21.64, 53.17, ...
Jun 24, 2013 - including autism spectrum disorder (ASD); those studies proposed that GSH and antioxidant enzymes have a ... for example, immune factors, environmental, neurochemical, ... effects in many diseases such as food allergy, diabetes mellitu
Aug 15, 2013 - the first data sets of the Human Connectome Project are being released. ..... simulating activity in neural circuits, opens up future potential.
Jun 26, 2013 - Abstract. Background: We conducted a prospective study to investigate the presence of microfungal contamination in the water supply system of the Oncology Paediatric Institute, SÃ£o Paulo â Brazil after the occurrence of one invasive
Mar 16, 2011 - investigative tool for screening or diagnosis of patients at risk of, .... Cartwright, C.A.; Meisler, A.I.; Eckhart, W. Activation of the pp60 c-src.
Antibiotic-associated diarrhea or colitis (AAD or AAC) can be caused by nearly all kinds of antibiotics. While Clostridi- um difficile is the most frequently identified ...
reported infrequently, infection is an acknowledged risk of flexible ... to investigate endoscopic transmission of infectious organisms and from our own and others ...
12 Nov 1999 - housekeeping gne, I0-actin. The cDNA from ...... EHP online articles contain convenient links to PubMed-the National Library of Medicine's free.
Oct 7, 2013 - infiltrated by T- and B-lymphocytes, macrophages, natural killer cells, dendritic .... He called .... as the short-lived mucosal or long-lived connective tissue subtypes .... suggested [119, 124] that the MCs aggregation around prostate
For anti-tumor efficacy studies, NHS-. muIL12 or rMuIL-12 (R&D Systems) was injected s.c. into the inner leg contralateral to the tumor. Tecemotide is a liposomal vaccine encapsulating monophosphoryl lipid A and a 25-mer peptide derived from the huma
that reduction of the nitro group is an essential feature in the embryotoxic mechanism. .... aromatic nitro compounds (12) and quinone/quinonoids. (13).
May 16, 2013 - Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei. Tumori (IRST), IRCCS, 47014 Meldola, Italy; ...
May 1, 2011 - ... enhances glucose-stimulated insu- lin secretion in mice. Cell Metab, 2005; 2: 105â17. Hypothesis. Med Sci Monit, 2011; 17(5): HY5-9. HY8 ...
Feb 7, 2013 - Chen, J.; Delannoy, M.; Odwin, S.; He, P.; Trush, M.A.; Yager, J.D. Enhanced mitochondrial gene transcript, ATP, bcl-2 protein levels, and ...
Chronic Obstructive Pulmonary Disease (COPD) is a respiratory condition associated .... the airways in response to a given stimulus (eg, LPS) although it is clear ...
Dec 11, 2012 - ... three times, followed by 50% ACN several times, and dried in a vacuum .... involvement of DOK-2 and phosphorylation of RGS proteins.
Oct 21, 2013 - HYPOTHESIS AND THEORY ARTICLE · published: 21 ..... neuronal circuits and that it may be the effects on the inhibitory neuronal circuits that ...
Apr 4, 2009 - cGy tumor dose in 39 fractions of 18 megavolt X-rays. The patient .... with multiple other serious comorbidities, and a low-risk prostate cancer is ...
highlight the role of CARD9 as a potential target in inflammation-related cardiovascular pathologies. Keywords: inflammation, heart failure, pressure-overload, ...
Aug 8, 2016 - that support the hypothesis that ammonia is a key factor contributing to AD progression. ... Effects include disruption of cellular energy metabolism, ... urea and deamination of amino acids (Marcaggi and Coles, 2001). ... a dropping pH
first-line setting.5 Tumor recurrences are common ... Keywords: biomarkers, immunotherapy, lung cancer, PD-L1, STAT3. Received: 21 ..... Niclosamide.
MOLECULAR MEDICINE REPORTS 10: 10-14, 2014
Monoglucosyl‑rutin as a potential radioprotector in mammalian cells SHIGEAKI SUNADA1, HIROSHI FUJISAWA2, IAN M. CARTWRIGHT3, JUNKO MAEDA3, COLLEEN A. BRENTS3, KAZUE MIZUNO4, YASUSHI AIZAWA5, TAKAMITSU A. KATO3 and MITSURU UESAKA1,2,6 Departments of 1Nuclear Engineering and Management and 2Bioengineering, School of Engineering, The University of Tokyo, Tokyo 113‑8656, Japan; 3Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO 80523, USA; 4Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo 113‑8656; 5Research and Development Group, Toyo Sugar Refining Co., Ltd., Yoto Bldg., Tokyo 103‑0046; 6Nuclear Professional School, School of Engineering, The University of Tokyo, Naka, Ibaraki 319-1188, Japan Received October 5, 2013; Accepted March 4, 2014 DOI: 10.3892/mmr.2014.2181 Abstract. In the present study, the role of monoglucosyl‑rutin as a potential radioprotector was investigated using mammalian cell culture models. Cell survival and DNA damage were assessed using colony formation, sister chromatid exchange and γH2AX assays. It was demonstrated that monoglucosyl‑rutin was able to increase cell survival when exposed to ionizing radiation, possibly by decreasing the amount of base damage experienced by the cell. However, the present study also demonstrated that, despite monoglucosyl‑rutin exhibiting radioprotective effects at low doses, high doses of monoglucosyl‑rutin led to a decrease in plating efficiency and an increased doubling time. This effect may be due to double‑strand breaks caused by high concentrations of monoglucosyl‑rutin. Introduction Ionizing radiation is an important clinical tool for the treatment of cancer. However, it presents potential harmful effects for human health, including acute radiation syndrome, mutagenesis and carcinogenesis. To increase the effectiveness of ionizing radiation it is critical to find a way to mitigate the
to: Professor Mitsuru Uesaka, Nuclear Professional School, School of Engineering, The University of Tokyo, 2‑22 Shirane‑Shirakata, Tokai, Naka, Ibaraki 319‑1188, Japan E‑mail: [email protected] Dr Takamitsu A. Kato, Department of Environmental and Radiological Health Sciences, Colorado State University, 1618 Campus Delivery, Fort Collins, CO 80523, USA E‑mail: [email protected]
damaging effect of ionizing radiation on healthy tissues surrounding the tumor. In addition to use with radiotherapy, potential radioprotectors may also be useful for the protection of radiation workers who are exposed to low or moderate levels of radiation on a semi‑frequent basis. When tissues are irradiated with low linear energy transfer (LET) radiation, for example X‑rays or γ‑rays, DNA is primarily damaged indirectly through free radicals. The free radicals are formed when the ionizing radiation interacts with water within the cells. The free radicals that are formed are highly reactive and easily interact with and damage DNA if they form in a close proximity to the DNA itself. Indirect DNA damage contributes to approximately two thirds of ionizing events during low LET ionizing radiation (1). There are two types of free radicals, short‑ and long‑lived radicals. Long‑lived radicals are able to induce DNA lesions, for example DNA base damage, however, do not cause serious lesions, including DNA double‑strand breaks. The short‑lived radicals are able to induce double‑strand breaks and thus are the most damaging and potentially harmful type of free radical (2). Since DNA damage in low LET radiation mainly occurs indirectly, the majority of classical radiation protectors, including dimethyl sulfoxide and WR‑2721, are radical scavengers that inhibit reactive oxygen species interacting with DNA (3,4). Natural flavonoids, such as quercetin and rutin, are known antioxidants (5). Previous studies have suggested that these flavonoids may protect cells and mice from ultra‑violet radiation and ionizing radiation (6,7). These flavonoids are extremely insoluble in water, which has prevented in depth studies into their potential use as radioprotectors. In an effort to increase their water solubility, modified flavonoids have been available, and one such flavonoid is monoglucosyl-rutin (αG‑rutin PS™) (8,9). I n the present st udy, the protective effect of monoglucosyl‑rutin against radiation was investigated in mammalian Chinese hamster ovary (CHO) 10B2 cells. It was hypothesized that irradiated cells treated with monoglucosyl‑rutin would have an increased survival rate when
SUNADA et al: MONOGLUCOSYL-RUTIN AS A POTENTIAL RADIOPROTECTOR
compared with the control cells, and that monoglucosyl‑rutin may be a potential free radical scavenger. Materials and methods Cell culture. CHO10B2 cells were grown in α‑minimum essential medium (α‑MEM; Invitrogen Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS; HyClone Laboratories, South Logan, UT, USA), antibiotic‑antimycotic (anti-anti; Invitrogen Life Technologies) in a humidified 5% CO2 atmosphere at 37˚C. Exponentially growing log phase cells were used in the present study. Normal human fibroblast cells, AG1521, were grown in α‑MEM supplemented with 15% FBS and anti‑anti. Only cells with passages lower than 12 were used. Contact inhibited G0/G1‑phase cells were used for the experiments. Drug treatment. Monoglucosyl‑rutin, an enzymatically modified form of rutin (Fig. 1), was supplied by Toyo Sugar Refining Co., Ltd. (Tokyo, Japan). Monoglucosyl‑rutin was dissolved in phosphate‑buffered saline (PBS) and filtered for sterilization. Monoglucosyl‑rutin was freshly prepared for each experiment and was added to the cell culture 1 h prior to the beginning of the experiment. Irradiation. Irradiation was performed using a J.L. Shepherd Model Mark I‑68 6000Ci 137Cs irradiator (J.L. Shepherd and Associates, San Fernando, CA, USA) at room temperature and at a dose rate of 250 cGy/min. Growth inhibition assay. To measure the cell doubling time, CHO cells were seeded at a density of 50,000 cells/P‑60 cell culture dish with various concentrations of monoglucosyl‑rutin, and the number of cells was counted twice a day (>8 h intervals) for 4 days. Cell doubling time for each condition was calculated using GraphPad Prism 6 software (GraphPad Software, San Diego, CA, USA). Three independent experiments were conducted. Cell survival assay. Cell survival was measured using a standard clonogenic assay. CHO cells were seeded at a density designed to yield ~100 viable colony‑forming cells/P‑60 cell culture dish subsequent to treatment with a combination of monoglucosyl‑rutin and ionizing radiation. The colonies were scored 7‑8 days after treatment. The dishes were then treated with 100% ethanol to fix colonies and stained with 0.1% crystal violet solution. The colonies containing more than 50 cells were recorded as reproductively viable surviving cells. Cell survival curves were drawn using GraphPad Prism software with linear quadratic regression. Three independent experiments were conducted. Immunostaining for γH2AX foci formation. The fixation and staining methods used for immunocytochemistry were performed as previously described (10). For immunostaining, AG1521 fibroblast cells were cultured on chamber slides and synchronized to the G0/G1 phases by contact inhibition. Following 30 min of treatment with monoglucosyl‑rutin and radiation exposure at 37˚C, the cells were fixed in 4% paraformaldehyde for 15 min, washed in PBS and then treated with 0.5%
Triton X‑100 for a further 10 min. Non‑specific binding sites were inhibited using PBS with 10% goat serum at 4˚C overnight. The chamber slides were then incubated with mouse monoclonal anti‑γ‑H2AX antibody (Millipore, Billerica, MA, USA) for 1 h, washed three times in PBS and incubated with Alexa 488 conjugated goat anti‑mouse secondary antibody (Invitrogen Life Technologies) for 1 h at 37˚C. The cells were washed four times in PBS and the nuclei were stained with Antifade Gold with DAPI solution (Invitrogen Life Technologies). Images of the cells were captured using a Z‑stage motorized Zeiss Axioskop with Metamorph system (Carl Zeiss AG, Jena, Germany). The z‑stacked images were stored and 50 cells from these were later scored in three independent experiments. Sister chromatid exchange (SCE) assay. CHO cells were synchronized into G1‑phase by mitotic shake‑off (11) and incubated for 2 h. Then, following treatment with monoglucosyl‑rutin and radiation exposure, the cells were incubated with 10 µM BrdU for two rounds of cell replication. Colcemid was added and the cells were harvested and treated with 75 mM KCl, fixed with methanol:acetic acid (3:1) solution and placed onto slides. The slides were stained with Hoechst 33258 for 30 min, immersed in PBS and then exposed to a black light source at 55˚C for 30 min. The slides were subsequently treated with 2X saline sodium citrate solution at 70˚C for 30 min. Finally, the slides were stained with filtered 10% Giemsa solution in Gurr solution for 5 min. Metaphase images were obtained using an Olympus BX51 microscope equipped with a Q‑imaging Aqua Cooled CCD camera with Q‑capture Pro software (Olympus, Tokyo, Japan). The SCE frequency was scored for each chromosome. At least 50 metaphase cells were scored for each three independent experiments. Statistical analysis. Statistical comparison of the mean values was performed using a t‑test with GraphPad Prism 6. P<0.05 was considered to indicate a statistically significant difference. Error bars indicate the standard error of the mean. Results Cellular toxicity of monoglucosyl‑rutin. To assess the cellular toxicity of monoglucosyl‑rutin, the cell doubling time and plating efficiency of CHO cells were investigated. To investigate cell doubling time, CHO cells were treated with varying concentrations of monoglucosyl‑rutin during growth. The total cell numbers were counted every 12 h to determine the cell doubling time for each treatment condition. As shown in Fig. 2, unexposed CHO cells exhibited an average doubling time of 12.8 h. Monoglucosyl‑rutin significantly increased cell doubling time starting at concentrations as low as 0.1%. The IC50 for cells treated with monoglucosyl‑rutin was 0.3% when the doubling time increased to 23.9 h. In addition to cell doubling time, the effect of monoglucosyl‑rutin on cell plating efficiency was also investigated. CHO cells were treated with varying concentrations of monoglucosyl‑rutin for 1 h and 100 cells were plated. Following seven days, the viable colonies were analyzed. As shown in Fig. 3, the plating efficiency of the treated cells was not significantly affected until 0.3% monoglucosyl‑rutin was applied and the plating efficiency significantly decreased to 61%, compared with 77% in the control cells.
MOLECULAR MEDICINE REPORTS 10: 10-14, 2014
Figure 1. Chemical structure of rutin and monoglucosyl‑rutin.
Figure 2. Cell doubling time of CHO10B2 cells exposed to various concentrations of monoglucosyl‑rutin. Error bars indicate the standard error of the mean.
Radioprotection in cell survival. To assess the role of monoglucosyl‑rutin as a potential radioprotector, cell survival was investigated using a colony formation assay. CHO cells were treated with 0.1 or 0.3% monoglucosyl‑rutin for 1 h and then exposed to various doses of radiation. The irradiated cells were plated and the number of surviving cells was determined. As shown in Fig. 4, the cells treated with 0.1% monoglucosyl‑rutin exhibited a statistically increased cell viability at 2 Gy when compared with the control cells. The cells treated with 0.3% monoglucosyl‑rutin demonstrated a significant increase in survival at doses greater than 2 Gy. Radioprotection in DNA damage. In order to determine the effect of monoglucosyl‑rutin on the prevention of radiation‑induced DNA damage, the number of induced SCEs and induced γH2AX foci were analyzed. To determine the effect of monoglucosyl‑rutin on the prevention of DNA base damage, the number of 2 Gy γ‑ray‑induced SCEs were analyzed per chromosome. As shown in Fig. 5, monoglucosyl‑rutin significantly decreased the number of SCEs per chromosome at all concentrations compared with non‑treated cells. Additionally, the effect of monoglucosyl‑rutin on double‑strand breaks was
Figure 3. Cell plating efficiency of CHO10B2 cells exposed to various concentrations of monoglucosyl‑rution. Error bars indicate the standard error of the mean.
also investigated by comparing the number of induced‑γH2AX foci in treated and untreated cells. As shown in Fig. 6, at concentrations of 0.5 and 1%, monoglucosyl‑rutin increased the number of γH2AX foci in unexposed and exposed fibroblasts. At lower concentrations used to determine cell survival and SCE, the monoglucosyl‑rutin‑treated cells exhibited statistically similar numbers of γH2AX foci with and without radiation. Discussion The present study demonstrated that monoglucosyl‑rutin exhibits a wide range of effects in mammalian cells. Despite the ability of monoglucosyl‑rutin to protect cells from radiation at low concentrations, it was observed that at elevated doses cells experienced an increase in baseline DNA damage. These results are in accordance with previous studies demonstrating that natural flavonoids have beneficial and negative effects on cells (12). As demonstrated in a previous study, several flavonoids have been used to protect against radiation due to their ability to capture radiation‑induced radicals in vitro and in vivo (7). However, it was also reported that certain flavonoids function as DNA‑dependent protein kinase inhibitors (12).
SUNADA et al: MONOGLUCOSYL-RUTIN AS A POTENTIAL RADIOPROTECTOR
Figure 4. Cell survival of CHO10B2 cells at various doses of γ radiation. Open square indicates the control cells, open circle indicates cells treated with 0.1% monoglucosyl‑rutin and open triangle indicates cells treated with 0.3% monoglucosyl‑rutin. Error bars indicate standard error of the mean.
Figure 5. Number of radiation-induced SCEs per chromosome in CHO10B2 cells when exposed to 2 Gy of γ radiation. The error bars indicate the standard error of the mean. SCE, sister chromatid exchange.
Through colony formation assays it was demonstrated that at a concentration of 0.3%, monoglucosyl‑rutin increases cell survival in cells exposed to 2 Gy. Concentrations of 0.1% monoglucosyl‑rutin, however, only increased cell survival in cells exposed to 2 Gy but not 8 Gy. When the cells were analyzed for SCE and γH2AX foci, it was observed that all doses of monoglucosyl‑rutin decreased the number of radiation‑induced SCE events, however, had no effect on the number of γH2AX foci formed. These results suggest that monoglucosyl‑rutin prevents DNA base damage caused by ionizing radiation. This indicates that monoglucosyl‑rutin may inhibit long‑lived radicals, however, not short‑lived radicals which cause the most harm to cells, thus only a slight increase in cell survival was observed. The limited effect of monoglucosyl‑rutin on cell survival may also be attributed to the size of the chemical, which
Figure 6. Average number of γH2AX foci/cell in normal human fibroblasts (AG1521) treated with various concentrations of monoglucosyl‑rutin and exposed to 0 or 1 Gy of γ radiation. Treatment dose is indicated in the figure legend. The error bars indicate the standard error of the mean.
has a molecular weight (MW) of >700 Da. Compounds with a MW of >500 Da tend to not be absorbed through the cell membrane (13,14). This may potentially explain why monoglucosyl‑rutin was found to be effective at inhibiting double‑strand breaks in vitro in a previous study (15), however, demonstrated no effect in vivo in the present study. Finally, it was noted in the present study that monoglucosyl‑rutin had an effect on the plating efficiency and doubling time of the treated cells. Cell doubling time and plating efficiency were significantly affected at concentrations of monoglucosyl‑rutin ≥0.3%. This is in accordance with the data which demonstrated that there was a statistical increase in γH2AX foci in cells treated with 0.5% monoglucosyl‑rutin. Despite monoglucosyl‑rutin being able to inhibit the formation of radiation‑induced SCEs, the drug itself causes DNA double‑strand breaks. These results demonstrated that there is a narrow window between doses that are potentially beneficial and ones that cause additional DNA damage to the cells. In conclusion, the present study demonstrated that monoglucosyl‑rutin is able to decrease the number of radiation‑induced SCEs and increase cell survival at concentrations that do not significantly increase cellular toxicity. This increase in cell survival is possibly due to the ability of monoglucosyl‑rutin to inhibit the formation of long‑lived radicals, thus protecting against DNA base damage. At higher concentrations, however, it was revealed that treatment with monoglucosyl‑rutin results in double‑strand breaks, leading to increased cell doubling time and a decrease in overall cell survival, potentially limiting the use of monoglucosyl‑rutin as a radioprotector. The present study demonstrated that in vivo exposure to monoglucosyl‑rutin does not produce the same results as in vitro experiments, and this is most likely due to the inability of monoglucosyl‑rutin to enter the cell owing to its large MW. Acknowledgements This study was partially supported by the Colorado State University start up fund (TK) and the collaborative research fund from Toyo Sugar Refining Co., Ltd. (MU).
MOLECULAR MEDICINE REPORTS 10: 10-14, 2014
References 1. Schulte‑Frohlinde D: Comparison of mechanisms for DNA strand break formation by the direct and indirect effect of radiation. Basic Life Sci 38: 19‑27, 1986. 2. Koyama S, Kodama S, Suzuki K, Matsumoto T, Miyazaki T and Watanabe M: Radiation‑induced long‑lived radicals which cause mutation and transformation. Mutat Res 421: 45‑54, 1998. 3. Howel l RW, Goddu SM, Bishaye e A a nd Rao DV: Radioprotection against lethal damage caused by chronic irradiation with radionuclides in vitro. Radiat Res 150: 391‑399, 1998. 4. Rasey JS, Nelson NJ, Mahler P, Anderson K, Krohn KA and Menard T: Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR‑2721: LD50 studies and 35S‑WR‑2721 biodistribution. Radiat Res 97: 598‑607, 1984. 5. Alia M, Mateos R, Ramos S, Lecumberri E, Bravo L and Goya L: Influence of quercetin and rutin on growth and antioxidant defense system of a human hepatoma cell line (HepG2). Eur J Nutr 45: 19‑28, 2006. 6. Choquenet B, Couteau C, Paparis E and Coiffard LJ: Quercetin and rutin as potential sunscreen agents: determination of efficacy by an in vitro method. J Nat Prod 71: 1117‑1118, 2008. 7. Benavente‑Garcia O, Castillo J, Lorente J and Alcaraz M: Radioprotective effects in vivo of phenolics extracted from Olea europaea L. leaves against X‑ray‑induced chromosomal damage: comparative study versus several flavonoids and sulfur‑containing compounds. J Med Food 5: 125‑135, 2002.
8. Shimoi K, Yoshizumi K, Kido T, Usui Y and Yumoto T: Absorption and urinary excretion of quercetin, rutin, and alphaG‑rutin, a water soluble flavonoid, in rats. J Agric Food Chem 51: 2785‑2789, 2003. 9. Matsunaga K, Yoshimi N, Shimoi K, et al: Inhibitory effects of dietary monoglucosyl‑rutin on azoxymethane‑induced colon carcinogenesis in rats. Asian Pac J Cancer Prev 1: 211‑216, 2000. 10. Maeda J, Yurkon CR, Fujisawa H, et al: Genomic instability and telomere fusion of canine osteosarcoma cells. PLoS One 7: e43355, 2012. 11. Tobey RA and Ley KD: Regulation of initiation of DNA synthesis in Chinese hamster cells. I. Production of stable, reversible G1‑arrested populations in suspension culture. J Cell Biol 46: 151‑157, 1970. 12. Izzard RA, Jackson SP and Smith GC: Competitive and noncompetitive inhibition of the DNA‑dependent protein kinase. Cancer Res 59: 2581‑2586, 1999. 13. Camenisch G, Alsenz J, van de Waterbeemd H and Folkers G: Estimation of permeability by passive diffusion through Caco‑2 cell monolayers using the drugs' lipophilicity and molecular weight. Eur J Pharm Sci 6: 317‑324, 1998. 14. Bos JD and Meinardi MM: The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 9: 165‑169, 2000. 15. Yoshikawa Y, Mori T, Suzuki M, Imanaka T and Yoshikawa K: Comparative study of kinetics on DNA double‑strand break induced by photo‑ and gamma‑irradiation: Protective effect of water‑soluble flavonoids. Chem Phys Lett 501: 146‑151, 2010.